Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So,
» Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Following a market correction in 2022 of about 20%, this year has been topsy turvy with some stocks doubling and others lagging like an anchor is tied to their share price.
PetMed Express falls into that latter category as losses mounted but the underwhelming performance has created a potential opening for value investors to get in at really low prices.
» Read more about: Market Commentary: 1 Pet Stock You Would Be Barking Mad To Overlook »
Molina Healthcare is not widely known among investors but that may be about to change following 15 quarters straight of year-over-year revenue growth and a member base that has grown to approximately 5.2 million across 20 states as of the most recent quarter.
Strategic moves like acquiring My Choice Wisconsin,
» Read more about: 1 Undervalued Healthcare Stock Flying Under The Radar »
David Einhorn has made a name for himself as the founder of Greenlight Capital, which manages around $1.7 billion at last count in Q3 2023.
Interestingly, the fund has made a massive bet on another company with Green in its name, Green Brick Partners. It’s an unfamiliar name to many investors and even those who do know of it may wonder why such a huge position was established by Einhorn and his investment team.
» Read more about: Market Commentary: $1.7 Billion Fund Bets Massively On 1 Stock »
Despite his fame as Warren Buffett’s right-hand man, Charlie Munger, who recently passed away at 99, maintained a remarkably low public profile, letting his vast wisdom and sharp wit speak through his investments and rare, yet profound, public statements.
Charlie was renowned for his role as the vice chairman of Berkshire Hathaway and his partnership with Warren Buffett,
» Read more about: Market Commentary: How Charlie Got So Rich »
Starbucks, a name synonymous with coffee, has grown beyond a mere chain of coffee shops to become a global icon in the beverage industry.
Unlike your regular run-of-the-mill local coffee shop, Starbucks has scaled its operations globally, transcending cultural and geographical boundaries. Its global footprint, though, has created its own set of challenges involving complex logistics like supply chain management,
» Read more about: Spotlight: 8 Analysts Just Upped Guidance On This Coffee Giant »
Famously, it’s been said that the restaurant business is a horrible one. You have to pay the rent, the staff, the food costs, and keep the lights on, and when you’re done with all that you have to hope your menu is right, the chefs show up each day, and the customers like the food.
» Read more about: Market Commentary: 1 Food Stock That Defies All Odds »
Some stocks just don’t get a lot of notoriety but they deserve the plaudits. In the United States if you were to ask someone to name a digital payment processor, you would likely hear the names Square or Stripe, but the odds are Adyen wouldn’t rank highly in a poll.
It’s with good reason that the Dutch firm flies under-the-radar.
» Read more about: Market Commentary: Little-known Dutch Stock Is Soaring »
It’s no easy feat trying to track down a company that has been so consistent in growing its top line that each and every single quarterly report is accompanied by a declaration of year-over-year growth but that’s precisely the case with Humana over the past half decade.
If you were attempting to identify a perfect stock,
» Read more about: Market Commentary: 1 Healthcare Stock You Don’t Want To Miss »
When you think of AI plays, Airbnb is not the first company that springs to mind. Yet, Brian Chesky’s firm has made a splash by snapping up GamePlanner.ai for $200 million.
Although it’s not apparent at first glance how artificial intelligence plays into the Airbnb business model, a deeper dive reveals the genius behind the acquisition.
» Read more about: Market Commentary: 1 Unlikely AI Play You Should Not Ignore »
